Bank of New York Mellon Corp - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$51,281,000
-10.1%
551,745
-42.4%
0.01%
-18.2%
Q3 2021$57,031,000
-11.9%
957,698
+0.9%
0.01%
-15.4%
Q2 2021$64,746,000
-0.5%
949,366
+1.3%
0.01%0.0%
Q1 2021$65,058,000
-6.3%
937,591
+3.7%
0.01%
-13.3%
Q4 2020$69,451,000
+19.8%
903,961
+16.6%
0.02%
+7.1%
Q3 2020$57,982,000
+18.6%
775,253
-0.1%
0.01%
+7.7%
Q2 2020$48,869,000
+169.5%
776,320
+79.8%
0.01%
+116.7%
Q1 2020$18,135,000
+78.4%
431,823
+93.0%
0.01%
+100.0%
Q4 2019$10,164,000
+3.0%
223,786
+3.8%
0.00%0.0%
Q3 2019$9,867,000
-26.6%
215,587
-6.0%
0.00%
-25.0%
Q2 2019$13,445,000
+38.6%
229,307
+6.0%
0.00%
+33.3%
Q1 2019$9,699,000
-2.1%
216,346
-15.0%
0.00%0.0%
Q4 2018$9,909,000
-1.5%
254,426
+16.4%
0.00%0.0%
Q3 2018$10,063,000
-5.0%
218,670
-10.0%
0.00%0.0%
Q2 2018$10,594,000
+19.0%
243,007
+7.8%
0.00%
+50.0%
Q1 2018$8,905,000
+55.6%
225,466
+33.8%
0.00%0.0%
Q4 2017$5,724,000
+31.8%
168,537
-1.1%
0.00%
+100.0%
Q3 2017$4,343,000
+84.3%
170,336
+22.0%
0.00%0.0%
Q2 2017$2,356,000139,6760.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prosight Management, LP 139,528$6,083,0004.46%
Eversept Partners, LP 134,151$5,848,9842.68%
DAFNA Capital Management LLC 95,242$4,153,0001.94%
GREAT POINT PARTNERS LLC 302,000$13,167,0001.82%
Atika Capital Management LLC 190,000$8,284,0001.59%
Crawford Lake Capital Management, LLC 205,600$8,964,0001.57%
Crawford Lake Capital Management, LLC 205,688$8,968,0001.57%
Cormorant Asset Management, LP 450,000$19,620,0001.45%
SENZAR ASSET MANAGEMENT, LLC 11,123$485,0001.40%
Rhenman & Partners Asset Management AB 284,621$12,409,0001.27%
View complete list of ARENA PHARMACEUTICALS INC shareholders